Surging cases of COVID-19 to drive global coronavirus diagnostics market
According to TechSci Research report, “Global Coronavirus Diagnostics Market By Type of Test (Molecular v/s Serology), By User (Multiple v/s Single), By Full Test Time (1 Hour – 12 Hours, Less Than 60 Minutes, 13 Hours – 24 Hours, More Than 1 Day), By End User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Others), By Region, Competition, Forecast & Opportunities, 2026”, the global coronavirus diagnostics market is expected to reach USD15579.56 million by 2026 on account of increasing R&D activities related to coronavirus diagnostics and treatment by major companies and research laboratories around the globe. Additionally, increasing funding & grants by various governments around the world to find out efficient diagnostic and treatment methods is further expected to spur the market over the next few years. Furthermore, increasing healthcare spending and rising need to protect the population from such outbreaks are expected to positively impact the growth of market in the coming years. However, high cost of diagnostics can hamper the growth of market, especially in the developing economies in the near term. Additionally, limited availability of diagnostic kits can hinder the growth of market.
Browse 186 market data Figures spread throughover 110 Pages and an in-depth TOC on “Global Coronavirus Diagnostics Market”
https://www.techsciresearch.com/report/coronavirus-diagnostics-market/4574.html
The global coronavirus diagnostics market is segmented based on type of test, user, full test time, end user, company and region. Based on type of test, the market can be bifurcated into molecular and serological tests. The serology tests segment is expected to witness significant growth during the forecast period. Based on full test time, the market can be fragmented into less than 60 minutes, 1 hour to 12 hours, 13 hours – 24hours and more than 1 day. 1 hour to 12 hours segment is currently dominating the market is expected to do so in the forecast period as well as the methods that are available right now take this much duration in the diagnosis of COVID-19 since they involve real time PCR test followed by gene fingerprinting which usually takes time. The less than 60 minutes segment is also expected to witness significant growth during the forecast period because California-based molecular diagnostics company Cepheid Inc., a subsidiary of Danaher Corporation, has developed a rapid coronavirus diagnostic test with detection time of about 45 minutes and has got the approval from the United States Food and Drug Administration (FDA) also. Based on end user, the market can be segmented into hospitals, public health labs, private or commercial labs, physician labs and others. The hospitals segment is currently the dominating segment and is expected to continue to do in future as well owing to the presence of sophisticated diagnostic and treatment facilities in the hospitals.
F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc., Mylab Discovery Solutions Pvt. Ltd., Bio-Rad Laboratories, Inc., BioMerieux SA, GSK Biologicals SA, Altona Diagnostics GmbH, Seegene Inc., PerkinElmer, Inc., Quest Diagnostics Inc., Hologic, Inc., Quidel Corporation are some of the leading players operating in the global coronavirus diagnostics market. The companies operating in the market are increasingly focusing on developing low cost diagnostic kits that offer high efficiency and accuracy. For instance, recently Pune (India) based molecular diagnostic company Mylab Discovery Solutions Pvt. Ltd. has become the first Indian company to have received the validation for its COVID-19 diagnostic test kits also known as the Reverse Transcription Polymerase Chain Reaction (RT-PCR) tests by the Drug Controller of India, after the National Institute of Virology validated its test.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4574
Customers can also request for 10% free customization on this report.
“Europe and Asia Pacific are expected to dominate the coronavirus diagnostics market during the forecast period. Increasing investments in R&D activities along with strong support from the governments in both the regions are further expected to create huge market opportunities for diagnostic players over the next few years.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Coronavirus Diagnostics Market By Type of Test (Molecular v/s Serology), By User (Multiple v/s Single), By Full Test Time (1 Hour – 12 Hours, Less Than 60 Minutes, 13 Hours – 24 Hours, More Than 1 Day), By End User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Others), By Region, Competition, Forecast & Opportunities, 2026” has evaluated the future growth potential of global coronavirus diagnostics market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global coronavirus diagnostics market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web: https://www.techsciresearch.com